The National Highway Traffic Safety Agency (NHTSA) said on Wednesday it is opening a safety probe into a fatal May 5 Tesla crash in California; amid growing concerns about the automaker’s driver assistance systems.
A Tesla crashed into an overturned truck on a highway near Fontana, California, killing the Tesla’s driver and injuring the truck driver and a motorist who had stopped to help him, the California Highway Patrol said.
The highway patrol report did not say whether the Tesla was operating on Autopilot, its semi-autonomous driving system, when the crash occurred.
The Mack truck had crashed and overturned five minutes earlier, blocking two lanes of the highway, the report said.
The company did not immediately respond to a request for comment.
NHTSA said it previously had opened 28 special investigations into Tesla crashes, with 24 pending.
Police in Texas last month said they believed an April 17 fatal crash; near Houston occurred with no one in the driver’s seat.
A preliminary government report Monday said footage from the owner’s home security cameras; showed the owner entering the driver’s seat and the passenger entering the front passenger seat.
Meanwhile, Covid-19 vaccines approved by the United States like Pfizer, Moderna and Johnson and Johnson have effectiveness against the B1617 variant of the virus that is predominant in India; which is experiencing one of the worst outbreaks of the pandemic, a top American health official said.
The observation is based on the latest data about the variant and the three major vaccines approved by the United States; said Dr Francis Collins, Director of National Institute of Science.
“The data is coming in, and it looks very encouraging that the U.S.-approved vaccines, the Pfizer; the Moderna, the J&J, do have effectiveness against this variant called B1617,” Collins told the media.
“It’s a little less effective in that case than some of the others; but it looks like it ought to be good enough to make Americans protected. And that’s really a good thing to hear,” he said in response to a question.